Your browser doesn't support javascript.
loading
Targeted protein degradation: from small molecules to complex organelles-a Keystone Symposia report.
Cable, Jennifer; Weber-Ban, Eilika; Clausen, Tim; Walters, Kylie J; Sharon, Michal; Finley, Daniel J; Gu, Yangnan; Hanna, John; Feng, Yue; Martens, Sascha; Simonsen, Anne; Hansen, Malene; Zhang, Hong; Goodwin, Jonathan M; Reggio, Alessio; Chang, Chunmei; Ge, Liang; Schulman, Brenda A; Deshaies, Raymond J; Dikic, Ivan; Harper, J Wade; Wertz, Ingrid E; Thomä, Nicolas H; Slabicki, Mikolaj; Frydman, Judith; Jakob, Ursula; David, Della C; Bennett, Eric J; Bertozzi, Carolyn R; Sardana, Richa; Eapen, Vinay V; Carra, Serena.
Afiliación
  • Cable J; PhD Science Writer, New York, New York.
  • Weber-Ban E; Institute of Molecular Biology and Biophysics, ETH Zurich, Zurich, Switzerland.
  • Clausen T; Research Institute of Molecular Pathology (IMP), Vienna BioCenter and Medical University of Vienna, Vienna, Austria.
  • Walters KJ; Protein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland.
  • Sharon M; Department of Bimolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
  • Finley DJ; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.
  • Gu Y; Department of Plant and Microbial Biology and Innovative Genomics Institute, University of California, Berkeley, California.
  • Hanna J; Department of Pathology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
  • Feng Y; Princess Margaret Cancer Centre, University Health Network and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Martens S; Max Perutz Labs, University of Vienna, Vienna BioCenter (VBC), Vienna, Austria.
  • Simonsen A; Department of Molecular Medicine, Institute of Basic Medical Sciences and Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Hansen M; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Zhang H; Sanford Burnham Prebys Medical Discovery Institute, Program of Development, Aging, and Regeneration, La Jolla, California.
  • Goodwin JM; National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences and College of Life Sciences, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Reggio A; Casma Therapeutics, Cambridge, Massachusetts.
  • Chang C; Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.
  • Ge L; Molecular and Cell Biology, University of California, Berkeley, Berkeley, California.
  • Schulman BA; State Key Laboratory of Membrane Biology, Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.
  • Deshaies RJ; Department of Molecular Machines and Signaling, Max Planck Institute of Biochemistry, Martinsried, Germany.
  • Dikic I; Amgen, Inc., Thousand Oaks, California.
  • Harper JW; Institute of Biochemistry II, School of Medicine and Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt, Germany.
  • Wertz IE; Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts.
  • Thomä NH; Departments of Molecular Oncology and Early Discovery Biochemistry, Genentech, Inc., South San Francisco, California.
  • Slabicki M; Bristol Myers Squibb, Brisbane, California.
  • Frydman J; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Jakob U; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • David DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Bennett EJ; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Bertozzi CR; Biophysics Graduate Program, Department of Biology and Department of Genetics, Stanford University, Stanford, California.
  • Sardana R; Biohub, San Francisco, California.
  • Eapen VV; Division of CryoEM and Bioimaging, SSRL, SLAC National Accelerator Laboratory, Menlo Park, California.
  • Carra S; Department of Molecular, Cellular and Developmental Biology, College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, Michigan.
Ann N Y Acad Sci ; 1510(1): 79-99, 2022 04.
Article en En | MEDLINE | ID: mdl-35000205

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ubiquitina / Complejo de la Endopetidasa Proteasomal Límite: Humans Idioma: En Revista: Ann N Y Acad Sci Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ubiquitina / Complejo de la Endopetidasa Proteasomal Límite: Humans Idioma: En Revista: Ann N Y Acad Sci Año: 2022 Tipo del documento: Article